TherapeuticsMD (TXMD) Share-based Compensation (2011 - 2026)
TherapeuticsMD's Share-based Compensation was $4,000 in Q2 2026, up 300.0% from $1,000 a year earlier and up 100.0% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Share-based Compensation (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, TherapeuticsMD's Share-based Compensation was $57,000 through Jun 30, 2026, down 29.6% year-over-year; for FY2025, it was $75,000, down 71.6% from FY2024.
- Share-based Compensation has now declined for four consecutive years, with a five-year compound annual growth rate of -62.9% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $264,000 in FY2024 (-79.2%), $1.27 million in FY2023 (-89.0%), $11.57 million in FY2022 (-36.2%) and $18.13 million in FY2021 (+69.7%).
- Quarterly Share-based Compensation has moved between $1,000 (Q2 2025) and $7.31 million (Q3 2021) over five years.
- Compared with a year earlier, Share-based Compensation was higher in two of the last seven quarters, with an average decline of 3.2%.
- The best year-over-year quarter for Share-based Compensation over five years was Q2 2026 (growth of 300.0%); the worst was Q2 2025 (a decline of 99.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | 4,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,000.00 |
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | 33,000.00 |
| Jun 30, 2024 | 96,000.00 |
| Mar 31, 2024 | 111,000.00 |
| Dec 31, 2023 | 116,000.00 |
| Sep 30, 2023 | 233,000.00 |
| Jun 30, 2023 | 437,000.00 |
| Mar 31, 2023 | 483,000.00 |
| Dec 31, 2022 | 3.01 Mn |
| Sep 30, 2022 | 4.30 Mn |
| Jun 30, 2022 | 2.20 Mn |
| Mar 31, 2022 | 2.06 Mn |
| Dec 31, 2021 | 5.33 Mn |
| Sep 30, 2021 | 7.30 Mn |
| Jun 30, 2021 | 2.50 Mn |
API Access
TherapeuticsMD Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();